Ghrelin may also influence cell migration and invasion capacity and consequently metastasis in several types of cancer by the GHSR/PI3K/Akt signaling pathway; in contrast, its role in breast and prostate cancers is controversial [18,60,61]. Here, AKT1 is linked to prostate carcinoma.